Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. The large number of journeys and participation in events have enabled him to build up a personal network.
As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders. Besides precious metals and energy sources, innovations from various industries are of particular interest.
Since the 1990s, extensive experience in the capital market from various perspectives has been gained. The anecdotes from this time are now paired with the expert knowledge from his business studies in the current commentaries in an entertaining way.
Commented by Mario Hose
Commented by Mario Hose on April 9th, 2024 | 06:00 CEST
Desert Gold Ventures CEO Jared Scharf: Allied Gold, Barrick Gold and Endeavour Mining are important neighbors
In today's interview, we have the opportunity to speak with the CEO of Desert Gold Ventures Inc. In recent years, Jared Scharf has expanded the company's land position in West Africa to 440 square kilometers and is located in the middle of the well-known gold companies Allied Gold, B2Gold, Barrick Gold and Endeavour Mining. The region in the West of Mali is one of the most important gold districts in the world and guarantees secure income for the state and a large number of different jobs for the population.
Read
Commented by Mario Hose on January 31st, 2024 | 06:30 CET
Manuka Resources Executive Chairman Dennis Karp on the potential in New Zealand after the change of government
Manuka Resources Limited is an Australian mining and exploration company with significant assets in the Cobar Basin in mid-western New South Wales. In addition to the November 2022 acquisition of Trans-Tasman Resources Limited (TTR), the owner of the VTM Taranaki Iron Sands Project, the company also holds all rights to two fully permitted mining projects, a gold project and a silver project, both located in the Cobar Basin. Due to a change of government in New Zealand, the TTR project has come under the spotlight. We find out more in an interview.
Read
Commented by Mario Hose on January 30th, 2024 | 06:30 CET
Cardiol Therapeutics Inc. CEO David Elsley on new therapies for acute myocarditis and recurrent pericarditis
Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company’s lead small molecule drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure.
Read
Commented by Mario Hose on January 11th, 2024 | 16:54 CET
Defense Metals Corp. CEO Craig Taylor on the potential of the Rare Earth project
Defense Metals Corp. is a mineral exploration and development company focused on the development of its 100% owned Wicheeda Rare Earth Element Deposit located near Prince George, British Columbia, Canada. Defense Metals Corp. trades on the TSX Venture Exchange under the symbol “DEFN”, in the United States, trading symbol “DFMTF” on the OTCQB and in Germany on the Frankfurt Exchange and other platforms under “35D”. We have the opportunity to talk to the CEO and get first-hand information.
Read
Commented by Mario Hose on July 3rd, 2023 | 07:30 CEST
Better than Nvidia and Apple? Up to 150% price potential beckons for aifinyo, sdm and HelloFresh
Those who have bet on Big Tech companies this year are delighted with the high price gains. But haven't Nvidia, Apple, and even some DAX stocks run hot? A repeat performance like in the first half of 2023 is rather unlikely. Taking part of the profits is a good idea. And as a new investment, a whole range of companies are "still" in the shadow of Big Tech and AI hype. It is exactly here where there is also an opportunity. Today, we look at small and mid-caps where analysts say there is over 100% upside. Take aifinyo, for example. The B2B fintech published strong numbers for 2022 and the start of 2023 was also promising. sdm has also had a good start to the current year. Due to two acquisitions, revenue and profit are expected to multiply in the current year.
Read
Commented by Mario Hose on October 24th, 2022 | 10:45 CEST
Rock Tech Lithium, TubeSolar, JinkoSolar - Breakthroughs in green innovation
The European Commission plans to reduce CO2 emissions by at least 55% by 2030 compared to 1990. This ambitious target for the current decade should lead to steady progress on the EU's path to climate neutrality by 2050. The key to achieving the climate turnaround is to increase the share of renewables in the overall energy mix. This should contribute at least 32% in around 8 years. But what sounds simple in theory is all the more difficult to implement in practice. That is because, in addition to raw materials that are already in short supply, there is a lack of open space for solar energy. Nevertheless, young companies, in particular, are achieving breakthroughs through innovation, which should be reflected in increased company values in the future.
Read
Commented by Mario Hose on September 26th, 2022 | 06:34 CEST
dynaCERT at the IAA TRANSPORTATION: generating more interest in the market every day!
Last week, the logistics industry meeting took place in Germany. All well-known companies from all parts of the world were represented at the IAA TRANSPORTATION in Hanover. The Canadian hydrogen pioneer dynaCERT was also there again. The technology for retrofitting diesel engines can be used now and today, while many other types of technologies still require costly infrastructures to be put in place. Ed Cordeiro is Director of Sales, Americas, and summarizes his impressions of the event.
Read
Commented by Mario Hose on September 12th, 2022 | 10:30 CEST
JinkoSolar, TubeSolar, Nel ASA - The innovations of the future
Less coal, more sun! In order to reduce the emission of greenhouse gases into the atmosphere, the share of renewable energy sources in Germany's gross electricity consumption is to increase to 65% by 2030. Instead of fossil fuels, more renewable energy sources are to serve as the basis for electricity production. In addition to the expansion of wind power plants at sea and on land, the German government is also pushing ahead with energy generation from solar plants. The transformation in the energy industry is creating new technology companies that could have significant potential and a bright future due to their innovation.
Read
Commented by Mario Hose on August 25th, 2022 | 05:07 CEST
dynaCERT CEO Jim Payne on carbon credits and VERRA
The Canadian hydrogen company dynaCERT is focused on the development of scalable technologies. In cooperation with VERRA in the USA, a process is currently being developed to certify the savings in energy consumption resulting from the use of dynaCERT products as Carbon Credits in the future. The market is large, so the trade fair 'IAA TRANSPORTATION' in Hannover, Germany, September 20-25, 2022, is eagerly awaited for where the company will make its presence clear. dynaCERT was significantly impacted by Corona lockdowns and has been rallying for the past few days, heading towards pre-Covid-19 pandemic levels, peaking at CAD 1.25. In Canada, more than 6.3 million shares were traded yesterday and at the close of the market, another 1.89 million shares were in the bid at CAD 0.30. CEO Jim Payne told us what the significance of the successful deal with VERRA will be. A taste of what to expect.
Read
Commented by Mario Hose on August 18th, 2022 | 10:28 CEST
Defence Therapeutics CEO Sébastien Plouffe on the next steps in the battle against cancer
A publicly traded biotechnology business called Defence Therapeutics is developing new vaccines and antibody-drug conjugates (ADC) products on its own proprietary platform. The ACCUM technology, which enables precise delivery of vaccine antigens or ADCs in their intact form to target cells, forms the basis of Defence Therapeutics' platform. As a result, catastrophic illnesses like cancer and infectious diseases can be combated with greater efficacy and potency. CEO Sébastien Plouffe gives us background on the company's latest development in the battle against cancer.
Read